MedPath

Bisphosphonate therapy in idiopathic avascular necrosis of femoral head in adolescents and young adults.

Not Applicable
Conditions
Health Condition 1: M858- Other specified disorders of bonedensity and structure
Registration Number
CTRI/2022/10/046412
Lead Sponsor
Department of Orthopedics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

All patients with radiological changes suggestive of avascular necrosis of hip who will give informed consent and willing for follow up. With Ficat arlet stage 1 or 2.

Exclusion Criteria

Patient with renal function impairment. Patient with ficat arlet stage 3 or more. Post traumatic avascular necrosis of femoral head.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Funcional outcome by pain visual analogue scale and Modified Harris hip score. Radiological outcome by Ficat arlet staging.Timepoint: Immediate after therapy, every 8 weeks for 24 weeks then every 6 months untill 2 years.
Secondary Outcome Measures
NameTimeMethod
eed for other intervention like surgical intervention if there is no improvement in functional and radiological outcome.Timepoint: Every 6 monthly.
© Copyright 2025. All Rights Reserved by MedPath